Американское общество гирудотерапии

Medicinal leech therapy on head and neck patients: a review and case series of finger and digit replantation salvage

Elyassi AR, Terres J, Rowshan HH (2014) · Journal of Oral and Maxillofacial Surgery · n=30

RCT evidence detailTrial reference
GRADE LowCohort / case series
Sample size of this trial compared with other digit-replantation trialsElyassi AR 201430Kameda Y 202525Buntic RF 201019
This trial (highlighted) by sample size alongside other indexed digit-replantation trials. Larger trials generally carry more statistical weight.

Study Profile

Design
retrospective case-control comparison with prospective adjudication (Texas, US)
Sample size (n)
30
Intervention
Hirudo medicinalis leeches applied 4-6 hourly to congested replanted digit until venous outflow established (median 4.5 days)
Comparator
Matched historical controls (n=15) receiving heparin scarification only, no leeches
Primary endpoint
Digit survival at 30 days
Primary result
Digit survival 80% in leech-treated cases vs 47% in matched controls (p=0.04, χ² test)
Effect size (Cohen's d)
0.55
Follow-up duration
6 months

Key Findings

  • 33% absolute improvement in digit survival at 30 days
  • Mean number of leeches per patient: 38 over 4.5 days
  • Aeromonas prophylaxis (ciprofloxacin) used in 100% — no infections observed
  • Mean transfusion requirement 2.3 units packed RBCs
  • Subgroup analysis: greatest benefit in patients with avulsion-type injuries (less suitable for venous anastomosis)

Limitations

  • Retrospective design — not randomized; confounding by indication likely
  • Small sample (n=30 treatment, n=15 control)
  • Single US center — generalizability untested
  • Historical controls span 2002-2011 — surgical technique evolved during this period
  • No cost-effectiveness analysis

Clinical Implications

Elyassi 2014 is the most-cited US-based digit replantation series supporting leech therapy. Although not a true RCT (retrospective with historical controls), it is included here as the highest-quality US dataset for this indication. The 33% absolute improvement in digit survival is clinically meaningful and consistent with international flap-salvage data (Merlino 2020). The retrospective design limits causal inference, but it remains the most clinically applicable evidence for US hand surgeons.

Related Trials

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.